<DOC>
	<DOCNO>NCT00323570</DOCNO>
	<brief_summary>This trial conduct United States America ( USA ) . The purpose study evaluate treatment Recombinant Faction VIIa Patients Severe Bleeding Due Trauma Please note trial trial F7TRAUMA-1711 ( NCT00184548 ) merge .</brief_summary>
	<brief_title>Evaluation Recombinant Factor VIIa Patients With Severe Bleeding Due Trauma</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>Trauma injury ( blunt and/or penetrate ) evidence active torso hemorrhage refectory standard treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>